{"id":"https://openalex.org/W2802373540","doi":"https://doi.org/10.1002/9783527808694.ch11","title":"Opicapone, a Novel Catechol\u2010O\u2010Methyltranferase Inhibitor ( COMT ) to Manage the Symptoms of P arkinson's Disease","display_name":"Opicapone, a Novel Catechol\u2010O\u2010Methyltranferase Inhibitor ( COMT ) to Manage the Symptoms of P arkinson's Disease","publication_year":2018,"publication_date":"2018-04-16","ids":{"openalex":"https://openalex.org/W2802373540","doi":"https://doi.org/10.1002/9783527808694.ch11","mag":"2802373540"},"language":"en","primary_location":{"id":"doi:10.1002/9783527808694.ch11","doi":"https://doi.org/10.1002/9783527808694.ch11","is_oa":false,"landing_page_url":"https://doi.org/10.1002/9783527808694.ch11","pdf_url":null,"source":{"id":"https://openalex.org/S4306464293","display_name":"Wiley eBooks","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"ebook platform"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Successful Drug Discovery","raw_type":"other"},"volume":{"id":"https://openalex.org/W2562367037","display_name":"Successful Drug Discovery"},"type":"book-chapter","is_traditional":true,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5081620292","display_name":"L\u00e1szl\u00f3 E. Kiss","orcid":"https://orcid.org/0000-0003-1306-8752","observed_orcids":["https://orcid.org/0000-0003-1306-8752"]},"institutions":[{"id":"https://openalex.org/I108511484","display_name":"Bial (Portugal)","ror":"https://ror.org/02htdjb57","country_code":"PT","type":"company","lineage":["https://openalex.org/I108511484"]}],"countries":["PT"],"is_corresponding":false,"raw_author_name":"L\u00e1szl\u00f3 E. Kiss","raw_affiliation_strings":["BIAL - Portela & Ca., S.A., Department of Research & Development, Laboratory of Chemistry, A\u0300 Avenida da Siderurgia Nacional, 4745-457 Coronado (S. Roma\u0303o e S. Mamede), Portugal","BIAL - Portela & Ca., S.A., Department of Research & Development, Laboratory of Chemistry, \u00c0 Avenida da Siderurgia Nacional, 4745-457 Coronado (S. Rom\u00e3o e S. Mamede), Portugal"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"BIAL - Portela & Ca., S.A., Department of Research & Development, Laboratory of Chemistry, A\u0300 Avenida da Siderurgia Nacional, 4745-457 Coronado (S. Roma\u0303o e S. Mamede), Portugal","institution_ids":["https://openalex.org/I108511484"]},{"raw_affiliation_string":"BIAL - Portela & Ca., S.A., Department of Research & Development, Laboratory of Chemistry, \u00c0 Avenida da Siderurgia Nacional, 4745-457 Coronado (S. Rom\u00e3o e S. Mamede), Portugal","institution_ids":["https://openalex.org/I108511484"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5064879720","display_name":"Maria Jo\u00e3o Bonif\u00e1cio","orcid":"https://orcid.org/0000-0002-4782-4686","observed_orcids":["https://orcid.org/0000-0002-4782-4686"]},"institutions":[{"id":"https://openalex.org/I108511484","display_name":"Bial (Portugal)","ror":"https://ror.org/02htdjb57","country_code":"PT","type":"company","lineage":["https://openalex.org/I108511484"]}],"countries":["PT"],"is_corresponding":false,"raw_author_name":"Maria Jo\u00e3o Bonif\u00e1cio","raw_affiliation_strings":["BIAL - Portela & Ca., S.A., Department of Research & Development, Laboratory of Pharmacology, A\u0300 Avenida da Siderurgia Nacional, 4745-457 Coronado (S. Roma\u0303o e S. Mamede), Portugal","BIAL - Portela & Ca., S.A., Department of Research & Development, Laboratory of Pharmacology, \u00c0 Avenida da Siderurgia Nacional, 4745-457 Coronado (S. Rom\u00e3o e S. Mamede), Portugal"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"BIAL - Portela & Ca., S.A., Department of Research & Development, Laboratory of Pharmacology, A\u0300 Avenida da Siderurgia Nacional, 4745-457 Coronado (S. Roma\u0303o e S. Mamede), Portugal","institution_ids":["https://openalex.org/I108511484"]},{"raw_affiliation_string":"BIAL - Portela & Ca., S.A., Department of Research & Development, Laboratory of Pharmacology, \u00c0 Avenida da Siderurgia Nacional, 4745-457 Coronado (S. Rom\u00e3o e S. Mamede), Portugal","institution_ids":["https://openalex.org/I108511484"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110356407","display_name":"Jos\u00e9 Rocha","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I108511484","display_name":"Bial (Portugal)","ror":"https://ror.org/02htdjb57","country_code":"PT","type":"company","lineage":["https://openalex.org/I108511484"]}],"countries":["PT"],"is_corresponding":false,"raw_author_name":"Jos\u00e9 Francisco Rocha","raw_affiliation_strings":["BIAL - Portela & Ca., S.A., Department of Research & Development, Clinical Research Unit, A\u0300 Avenida da Siderurgia Nacional, 4745-457 Coronado (S. Roma\u0303o e S. Mamede), Portugal","BIAL - Portela & Ca., S.A., Department of Research & Development, Clinical Research Unit, \u00c0 Avenida da Siderurgia Nacional, 4745-457 Coronado (S. Rom\u00e3o e S. Mamede), Portugal"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"BIAL - Portela & Ca., S.A., Department of Research & Development, Clinical Research Unit, A\u0300 Avenida da Siderurgia Nacional, 4745-457 Coronado (S. Roma\u0303o e S. Mamede), Portugal","institution_ids":["https://openalex.org/I108511484"]},{"raw_affiliation_string":"BIAL - Portela & Ca., S.A., Department of Research & Development, Clinical Research Unit, \u00c0 Avenida da Siderurgia Nacional, 4745-457 Coronado (S. Rom\u00e3o e S. Mamede), Portugal","institution_ids":["https://openalex.org/I108511484"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5078712323","display_name":"Patr\u0131\u0301cio Soares-da-Silva","orcid":"https://orcid.org/0000-0002-2446-5078","observed_orcids":["https://orcid.org/0000-0002-2446-5078"]},"institutions":[{"id":"https://openalex.org/I108511484","display_name":"Bial (Portugal)","ror":"https://ror.org/02htdjb57","country_code":"PT","type":"company","lineage":["https://openalex.org/I108511484"]},{"id":"https://openalex.org/I182534213","display_name":"Universidade do Porto","ror":"https://ror.org/043pwc612","country_code":"PT","type":"education","lineage":["https://openalex.org/I182534213"]},{"id":"https://openalex.org/I4405254940","display_name":"Centro de Investiga\u00e7\u00e3o Farmacol\u00f3gica e Inova\u00e7\u00e3o Medicamentosa","ror":"https://ror.org/02dtdp942","country_code":"PT","type":"facility","lineage":["https://openalex.org/I182534213","https://openalex.org/I4405254940"]}],"countries":["PT"],"is_corresponding":false,"raw_author_name":"Patr\u00edcio Soares\u2010 da\u2010Silva","raw_affiliation_strings":["BIAL - Portela & Ca., S.A., Department of Research & Development, A\u0300 Avenida da Siderurgia Nacional, 4745-457 Coronado (S. Roma\u0303o e S. Mamede), Portugal","MedInUP - Center for Drug Discovery and Innovative Medicines, University of Porto, Portugal","BIAL - Portela & Ca., S.A., Department of Research & Development, \u00c0 Avenida da Siderurgia Nacional, 4745-457 Coronado (S. Rom\u00e3o e S. Mamede), Portugal"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"BIAL - Portela & Ca., S.A., Department of Research & Development, A\u0300 Avenida da Siderurgia Nacional, 4745-457 Coronado (S. Roma\u0303o e S. Mamede), Portugal","institution_ids":["https://openalex.org/I108511484"]},{"raw_affiliation_string":"MedInUP - Center for Drug Discovery and Innovative Medicines, University of Porto, Portugal","institution_ids":["https://openalex.org/I182534213","https://openalex.org/I4405254940"]},{"raw_affiliation_string":"BIAL - Portela & Ca., S.A., Department of Research & Development, \u00c0 Avenida da Siderurgia Nacional, 4745-457 Coronado (S. Rom\u00e3o e S. Mamede), Portugal","institution_ids":["https://openalex.org/I108511484"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":1,"citation_normalized_percentile":{"value":0.05194805,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":93},"biblio":{"volume":null,"issue":null,"first_page":"319","last_page":"340"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10085","display_name":"Parkinson's Disease Mechanisms and Treatments","score":0.9282000064849854,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10085","display_name":"Parkinson's Disease Mechanisms and Treatments","score":0.9282000064849854,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12023","display_name":"Cholinesterase and Neurodegenerative Diseases","score":0.03350000083446503,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10274","display_name":"Heterocyclic Compound Synthesis and Bioactivity","score":0.002300000051036477,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/opicapone","display_name":"opicapone","score":0.9990000128746033},{"id":"https://openalex.org/keywords/catechol-o-methyltransferase-inhibitors","display_name":"catechol-O-methyltransferase inhibitors","score":0.9940000176429749},{"id":"https://openalex.org/keywords/parkinson-s-disease","display_name":"Parkinson's disease","score":0.9800000190734863},{"id":"https://openalex.org/keywords/levodopa","display_name":"levodopa","score":0.9470000267028809},{"id":"https://openalex.org/keywords/motor-fluctuations","display_name":"motor fluctuations","score":0.753000020980835},{"id":"https://openalex.org/keywords/once-daily-dosing","display_name":"once-daily dosing","score":0.7919999957084656},{"id":"https://openalex.org/keywords/drug-design-and-synthesis","display_name":"drug design and synthesis","score":0.7720000147819519},{"id":"https://openalex.org/keywords/adjunctive-therapy","display_name":"adjunctive therapy","score":0.7409999966621399}],"concepts":[{"id":"https://openalex.org/C185361966","wikidata":"https://www.wikidata.org/wiki/Q94291140","display_name":"Catechol-O-methyl transferase","level":4,"score":0.8390439748764038},{"id":"https://openalex.org/C2780304432","wikidata":"https://www.wikidata.org/wiki/Q300989","display_name":"Levodopa","level":4,"score":0.7438267469406128},{"id":"https://openalex.org/C2779734285","wikidata":"https://www.wikidata.org/wiki/Q11085","display_name":"Parkinson's disease","level":3,"score":0.695775032043457},{"id":"https://openalex.org/C2776976799","wikidata":"https://www.wikidata.org/wiki/Q416444","display_name":"Entacapone","level":5,"score":0.6809103488922119},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6584668159484863},{"id":"https://openalex.org/C2908591018","wikidata":"https://www.wikidata.org/wiki/Q4795512","display_name":"Decarboxylase inhibitor","level":5,"score":0.6479557156562805},{"id":"https://openalex.org/C513476851","wikidata":"https://www.wikidata.org/wiki/Q170304","display_name":"Dopamine","level":2,"score":0.5718712210655212},{"id":"https://openalex.org/C58824617","wikidata":"https://www.wikidata.org/wiki/Q421186","display_name":"Aromatic L-amino acid decarboxylase","level":3,"score":0.5318203568458557},{"id":"https://openalex.org/C2781413609","wikidata":"https://www.wikidata.org/wiki/Q7308373","display_name":"Regimen","level":2,"score":0.530408501625061},{"id":"https://openalex.org/C2776134090","wikidata":"https://www.wikidata.org/wiki/Q47495783","display_name":"Selegiline","level":4,"score":0.5237072706222534},{"id":"https://openalex.org/C2777453868","wikidata":"https://www.wikidata.org/wiki/Q420590","display_name":"Ropinirole","level":5,"score":0.521649181842804},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.49559271335601807},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.4842354953289032},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.45400285720825195},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.3620896339416504},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.11290621757507324},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.0},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.0},{"id":"https://openalex.org/C180754005","wikidata":"https://www.wikidata.org/wiki/Q80726","display_name":"Allele","level":3,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1002/9783527808694.ch11","doi":"https://doi.org/10.1002/9783527808694.ch11","is_oa":false,"landing_page_url":"https://doi.org/10.1002/9783527808694.ch11","pdf_url":null,"source":{"id":"https://openalex.org/S4306464293","display_name":"Wiley eBooks","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"ebook platform"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Successful Drug Discovery","raw_type":"other"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.98580002784729,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":40,"referenced_works":["https://openalex.org/W51589336","https://openalex.org/W102297612","https://openalex.org/W175006040","https://openalex.org/W294304874","https://openalex.org/W635575025","https://openalex.org/W1479935944","https://openalex.org/W1497529955","https://openalex.org/W1499453506","https://openalex.org/W1571415861","https://openalex.org/W1963824779","https://openalex.org/W1965128384","https://openalex.org/W2002243241","https://openalex.org/W2006164302","https://openalex.org/W2015587580","https://openalex.org/W2019345577","https://openalex.org/W2023765475","https://openalex.org/W2025897267","https://openalex.org/W2033881399","https://openalex.org/W2034770202","https://openalex.org/W2059945987","https://openalex.org/W2059952048","https://openalex.org/W2066821514","https://openalex.org/W2075857365","https://openalex.org/W2077878281","https://openalex.org/W2080194182","https://openalex.org/W2082492037","https://openalex.org/W2084950460","https://openalex.org/W2112120783","https://openalex.org/W2117446218","https://openalex.org/W2122137453","https://openalex.org/W2133834142","https://openalex.org/W2134886133","https://openalex.org/W2149040114","https://openalex.org/W2191356548","https://openalex.org/W2218385786","https://openalex.org/W2239722532","https://openalex.org/W2287706733","https://openalex.org/W2321049536","https://openalex.org/W2412946805","https://openalex.org/W2442383969"],"related_works":["https://openalex.org/W2473227408","https://openalex.org/W2078664151","https://openalex.org/W3201256568","https://openalex.org/W3028163694","https://openalex.org/W4317749953","https://openalex.org/W2588542533","https://openalex.org/W4214717514","https://openalex.org/W2117446218","https://openalex.org/W2625525210","https://openalex.org/W3108148252"],"abstract_inverted_index":{"This":[0],"chapter":[1],"focuses":[2],"on":[3],"the":[4,53,76,82,86,107,114,131],"design":[5],"and":[6],"synthesis":[7],"of":[8,21,57,78,85,110,134],"novel,":[9],"purely":[10],"peripherally":[11],"selective":[12],"catechol-O-methyltransferase":[13],"(COMT)":[14],"inhibitors":[15,46],"endowed":[16],"with":[17,47,59,100],"sufficiently":[18],"long":[19],"duration":[20],"action":[22],"that":[23,95],"would":[24],"ideally":[25],"make":[26],"them":[27],"suitable":[28],"for":[29,43,74,130],"a":[30,40],"much":[31],"simplified,":[32],"once-per-day":[33],"administration":[34,84],"regimen.":[35],"Undoubtedly":[36],"there":[37],"clearly":[38,93],"exists":[39],"definite":[41],"requirement":[42],"new":[44],"COMT":[45,96],"improved":[48],"clinical":[49,126],"profile":[50],"to":[51],"address":[52],"unmet":[54],"medical":[55],"needs":[56],"patients":[58],"central":[60],"nervous":[61],"system":[62],"(CNS)":[63],"disorders":[64],"such":[65],"as":[66],"Parkinson's":[67],"disease":[68],"(PD).":[69],"The":[70],"most":[71],"effective":[72],"medication":[73],"alleviating":[75],"symptoms":[77],"late-stage":[79],"PD":[80,119],"is":[81],"oral":[83],"dopamine":[87],"precursor":[88],"levodopa":[89],"(l-DOPA).":[90],"Clinical":[91],"studies":[92],"demonstrate":[94],"inhibitors,":[97,105],"in":[98,117,128],"combination":[99],"l-DOPA/amino":[101],"acid":[102],"decarboxylase":[103],"(AADC)":[104],"decrease":[106],"daily":[108],"dose":[109],"l-DOPA,":[111],"therefore":[112],"reducing":[113],"motor":[115],"fluctuations":[116],"advanced":[118,122],"patients.":[120],"Opicapone":[121],"into":[123],"phase":[124],"I":[125],"trial":[127],"2007":[129],"adjunctive":[132],"treatment":[133],"PD.":[135]},"counts_by_year":[{"year":2025,"cited_by_count":1}],"updated_date":"2026-11-07T11:25:07.637180","created_date":"2018-05-17T00:00:00"}